Esperion Therapeutics Stock Overlap Studies MESA Adaptive Moving Average

ESPR Stock  USD 2.62  0.08  2.96%   
Esperion Therapeutics overlap studies tool provides the execution environment for running the MESA Adaptive Moving Average study and other technical functions against Esperion Therapeutics. Esperion Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the MESA Adaptive Moving Average study function is designed to identify and follow existing trends. Esperion Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Fast Limit and Slow Limit to execute this module.

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Esperion Therapeutics price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.

Esperion Therapeutics Technical Analysis Modules

Most technical analysis of Esperion Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Esperion from various momentum indicators to cycle indicators. When you analyze Esperion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Esperion Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Esperion Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Esperion Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Esperion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Esperion Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Esperion Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Esperion Therapeutics, we also check how macroeconomic factors affect Esperion Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Dividend Yield0.380.34
Price To Sales Ratio2.652.52
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Esperion Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.132.618.87
Details
Intrinsic
Valuation
LowRealHigh
0.234.6310.89
Details
Naive
Forecast
LowNextHigh
0.073.309.56
Details
8 Analysts
Consensus
LowTargetHigh
10.1311.1312.35
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Esperion Therapeutics. Your research has to be compared to or analyzed against Esperion Therapeutics' peers to derive any actionable benefits. When done correctly, Esperion Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Esperion Therapeutics.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Esperion Therapeutics is a strong investment it is important to analyze Esperion Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Esperion Therapeutics' future performance. For an informed investment choice regarding Esperion Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Esperion Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Esperion Stock, please use our How to Invest in Esperion Therapeutics guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Esperion Stock analysis

When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Esperion Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Esperion Therapeutics. If investors know Esperion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Esperion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.03)
Revenue Per Share
1.128
Quarterly Revenue Growth
0.714
Return On Assets
(0.43)
Return On Equity
(2.61)
The market value of Esperion Therapeutics is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Esperion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Esperion Therapeutics' market value can be influenced by many factors that don't directly affect Esperion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Esperion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Esperion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esperion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.